— Know what they know.
Not Investment Advice
Also trades as: EMBCV (NASDAQ) · $vol 116M

EMBC NASDAQ

Embecta Corp.
1W: +5.7% 1M: -64.0% 3M: -68.6% YTD: -71.1% 1Y: -72.0% 3Y: -87.2%
$3.32
+0.00 (+0.00%)
 
Weekly Expected Move ±29.4%
$1 $2 $3 $4 $5
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Strong Sell · Power 29 · $197.0M mcap · 58M float · 2.95% daily turnover · Short 51% of daily vol

📊 Key Metrics

TTM
$1B
Revenue
-3.4% YoY
$112M
Net Income
+114.8% YoY
$205M
Free Cash Flow
+415.6% YoY
56.4%
Gross Margin
19.3%
Op. Margin
-1.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-16.1%
ROA9.4%
ROIC37.0%

Valuation

P/E1.7
P/B-0.3
EV/EBITDA5.2

Leverage

Debt/Equity-2.20
Current Ratio2.41
Interest Cov.2.8x

Quality Scores

Piotroski F6/9
Altman Z1.82
Beneish M-2.90

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms